MARSH & MCLENNAN COS (MMC)       173.18  +4.5 (+2.67%)

173.18  +4.5 (+2.67%)

US5717481023 - Common Stock - After market: 172.84 -0.34 (-0.2%)


Fundamental Rating

5

Overall MMC gets a fundamental rating of 5 out of 10. We evaluated MMC against 141 industry peers in the Insurance industry. While MMC has a great profitability rating, there are some minor concerns on its financial health. While showing a medium growth rate, MMC is valued expensive at the moment.




Profitability

Profitability Rating

7

MMC has a Return On Assets of 10.58%. This is amongst the best returns in the industry. The industry average is 0.87%. MMC outperforms 96% of its industry peers.
MMC has a Return On Equity of 35.41%. This is amongst the best returns in the industry. The industry average is 13.23%. MMC outperforms 93% of its industry peers.

MMC has a Profit Margin of 16.26%. This is better than the industry average of 6.95%.
The Piotroski-F score of MMC is 6.00. This is a neutral score and indicates average health and profitability for MMC.
VS Industry

ROA (10.58%) VS Industry: 96% outperformed.

-93.12
28.75

ROE (35.41%) VS Industry: 93% outperformed.

0.42
97.81

Profit Margin (16.26%) VS Industry: 80% outperformed.

-285.34
357.97

Valuation

Valuation Rating

0

The Forward Price/Earnings Ratio of 23.03 indicates a rather expensive current valuation of MMC.
When comparing the current price to the book value of MMC, we can conclude it is valued correctly. It is trading at 8.98 times its book value.
With a Price/Earnings Ratio of 25.73, MMC can be considered very expensive at the moment.
With a Price/Earning Ratio of 25.73, MMC is valued a higher than the industry average, which is at 10.57. 88% of the companies listed in the same industry are cheaper than MMC!

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
When comparing the price book ratio of MMC to the average industry price book ratio of 1.19, MMC is valued more expensive than its industry peers. 97% of the companies listed in the same industry are valued cheaper.
Compared to an average industry Enterprise Value to EBITDA ratio of 8.41, MMC is valued more expensive than its industry peers.
VS Industry

Price/Earnings (25.73) VS Industry: 12% outperformed.

81.22
1.44

Price/Book (8.98) VS Industry: 3% outperformed.

135.69
0.10

Enterprise Value/ EBITDA (17.31) VS Industry: 26% outperformed.

670.25
0.03

Growth

Growth Rating

4

The Earnings Per Share has grown by an nice 11.98% over the past year.
MMC shows quite a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 12.63% yearly.
Based on estimates for the next 5 years, MMC will show a small growth in Earnings Per Share. The EPS will grow by 9.84% on average per year.
The EPS growth is stable: in the next 5 years the growth will be about the same than in the last 5 years.

The Revenue has been growing slightly by 9.09% in the past year.
MMC shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 8.45% yearly.
MMC is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 4.06% yearly.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS12.63% 12.42% 11.98% 10.55% 10.31% 10.14% 9.84%
Revenue8.45% 9.86% 9.09% 6.25% 5.85% 5.83% 4.06%

Health

Health Rating

5

An Altman-Z score of 4.25 indicates that MMC is not in any danger for bankruptcy at the moment.
The Altman-Z score of MMC is much better than the industry average of 1.29. MMC has a better rating than 90% of its industry peers.
MMC has a Current Ratio of 1.04. This is a normal value and indicates that MMC is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.04 indicates that MMC should not have too much problems paying its short term obligations.

MMC has a Piotroski-F score of 6.00. This indicates an average health and profitability for MMC.
When comparing the Current Ratio of MMC to the average industry Current Ratio of 1.27, MMC is less able to pay its short term obligations than its industry peers. 91% of its industry peers have a better Current Ratio.
When comparing the Quick Ratio of MMC to the average industry Current Ratio of 1.27, MMC is less able to pay its short term obligations than its industry peers. 91% of its industry peers have a better Quick Ratio.
MMC has one of the worst Debt to Equity ratios in its industry. 82% of its industry peers require less debt for financing their operations.
VS Industry

Debt/Equity (1.09) VS Industry: 18% outperformed.

17.94
0.00

Quick Ratio (1.04) VS Industry: 9% outperformed.

0.56
10.37

Current Ratio (1.04) VS Industry: 9% outperformed.

0.56
10.37

Altman-Z (4.25) VS Industry: 90% outperformed.

-3.35
12.68

Dividend

Dividend Rating

6

The dividend of MMC is nicely growing with an annual growth rate of 8.17%!
MMC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
32.95% of the earnings are spent on dividend by MMC. This is a low number and sustainable payout ratio.
MMC has been paying a dividend for at least 10 years, so it has a reliable track record.

MMC has a Yearly Dividend Yield of 1.41%.
Compared to an average industry Dividend Yield of 2.38, MMC is paying slightly less dividend.
With a Dividend Yield of 1.41, MMC pays less dividend than the S&P500 average, which is at 2.47.
VS Industry

Dividend Yield (1.41%) VS Industry: 21% outperformed.

0.07
70.26
MMC Daily chart

MARSH & MCLENNAN COS173.18

NYSE:MMC (11/30/2022, 7:04:00 PM)+4.5 (+2.67%)

After market: 172.84 -0.34 (-0.2%)

Chartmill FA Rating
GICS Sector Financials
GICS IndustryGroup Insurance
GICS Industry Insurance
Earnings (Last) 10-20 2022-10-20/bmo Earnings (Next) 01-25 2023-01-25
Ins Owners 0.19% Inst Owners 88.47%
Market Cap 85.90B Analysts 70.91
Valuation
PE 25.73 Fwd PE 23.03
PEG (NY) 2.44 PEG (5Y) 2.04
P/S 4.12 P/B 8.98
EV/EBITDA 17.31
Dividend
Dividend Yield 1.41% Dividend Growth 8.17%
DP 32.95% Ex-Date 10-06 2022-10-06 (0.59)
Growth
EPS 1Y 11.98% EPS 3Y 12.42%
EPS 5Y 12.63% EPS growth Q2Q 9.26%
EPS Next Y 10.55% EPS Next 2Y 10.31%
EPS Next 3Y 10.14% EPS Next 5Y 9.84%
Revenue growth 1Y 9.09% Revenue growth 3Y 9.86%
Revenue growth 5Y 8.45% Revenue growth Q2Q 4.08%
Revenue Next Year 6.25% Revenue Next 2Y 5.85%
Revenue Next 3Y 5.83% Revenue Next 5Y 4.06%
Health
Current Ratio 1.04 Quick Ratio 1.04
Altman-Z 4.25 F-Score 6
Debt/Equity 1.09 WACC 7.77%
ROIC/WACC 6.89
Profitability
ROA 10.58% ROE 35.41%
ROICexgc 53.5% ROIC 13.83%
PM 16.26% OM 22.63%
Asset Turnover 0.65

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA